Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14Gastrointestinal 9Genitourinary 5Other hematologic neoplasm 3Lymphoid 3Thoracic 2Plasma cell 2Sarcoma 1Head & Neck 1Gynecologic 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Ovarian Neoplasms 2565Uterine Cervical Neoplasms 1684Endometrial Neoplasms 1008Fallopian Tube Neoplasms 729Carcinoma, Ovarian Epithelial 680Breast Neoplasms 673Neoplasms 436Carcinoma, Non-Small-Cell Lung 377Colorectal Neoplasms 370Pancreatic Neoplasms 302Stomach Neoplasms 301Uterine Cervical Dysplasia 273Prostatic Neoplasms 261Lung Neoplasms 250Melanoma 247Neoplasm Metastasis 214Peritoneal Neoplasms 197Carcinoma, Renal Cell 192Sarcoma 189Head and Neck Neoplasms 188Urinary Bladder Neoplasms 187Esophageal Neoplasms 186Recurrence 184Triple Negative Breast Neoplasms 179Uterine Neoplasms 176Vulvar Neoplasms 173Squamous Cell Carcinoma of Head and Neck 166Colonic Neoplasms 162Papillomavirus Infections 152Small Cell Lung Carcinoma 126

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Patient Participation × Gynecologic × Clear all
NCT05256576 2025-01-15

KORE

Charite University, Berlin, Germany

Phase NA Completed
465 enrolled
Gynecologic

Frailty, Fallopian Tube Neoplasms, Ovarian Neoplasms, Patient Participation, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡